<!DOCTYPE html>
<html>
<head>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
    <meta name="keywords" content="">
    <meta name="description" content="">
    <title>详细报告语句详情</title>
    <link href="../css/bootstrap.css" rel="stylesheet" />
    <link href="../css/style.css" rel="stylesheet" />
    <style type="text/css">
        .content-tips .paper-section{margin-bottom:0;min-width:450px;}
    </style>
</head>
<body>
<span id="gototop"></span>
<div>
    <div class="paper-txt P30">
        <div class="paper-section" style="margin-bottom:0;">
            <div class="font-bold MT5">
                该句相似度：<span class="g-font-color orange similarNum">54%</span>
            </div>
            <div class="MT30">
                <p class="font-bold">您的语句：</p>
                <span>两组总体的中位无进展生存期及总生存期为5.5个月和12.5个月。</span>
            </div>
        </div>
    </div>
    <div>
        <div class="tab-A">
            <ul class="tab-A-ul clearfix" tab-a="ul">
                <li class="active" data-id="学术期刊,学位论文,学术会议,书籍数据,互联网,自建库,all">
                    <span class="tab-text">综合</span>
                    <span class="tab-superscript">16</span>
                </li>
                <li data-id="tab,学术期刊,学位论文,学术会议,书籍数据,自建库,local">
                    <span class="tab-text">本地库</span>
                    <span class="tab-superscript">16</span>
                </li>
                <li data-id="互联网,5">
                    <span class="tab-text">互联网</span>
                    <span class="tab-superscript">0</span>
                </li>
            </ul>
        </div>
        <div class="none" tab="section" data-id="tab">
            <div class="tab-B clearfix">
                <div class="paper-section P30 PB0 clearfix">
                    <span class="tab-B-span pull-left">本地库</span>
                    <ul class="tab-B-ul pull-left clearfix" tab-b="ul">
                        <li class="active" data-id="tab,学术期刊,学位论文,学术会议,书籍数据,自建库,local">
                            <span class="tab-text">全部</span>
                            <span class="tab-superscript">16</span>
                            <span class="black-spacer"></span>
                        </li>
                        <li data-id="tab,学术期刊,1">
                            <span class="tab-text">期刊</span>
                            <span class="tab-superscript">6</span>
                            <span class="black-spacer"></span>
                        </li>
                        <li data-id="tab,学位论文,2">
                            <span class="tab-text">学位</span>
                            <span class="tab-superscript">6</span>
                            <span class="black-spacer"></span>
                        </li>
                        <li data-id="tab,学术会议,3">
                            <span class="tab-text">会议</span>
                            <span class="tab-superscript">1</span>
                            <span class="black-spacer"></span>
                        </li>
                        <li data-id="tab,书籍数据,4">
                            <span class="tab-text">图书</span>
                            <span class="tab-superscript">3</span>
                                                    </li>
                                            </ul>
                </div>
                <div class="g-line-row MT30 tab-pane-line"></div>
            </div>
        </div>
        <div class="content-tips">
            <div class="tab-content none" tab="section" data-id="1">
                <div class="paper-txt P30 paper-section clearfix">
                    <p class="g-font-color green pull-left">
                        在期刊库共找出相似内容：<span>6</span>个                    <p>
                    <div class="pull-right">
                        <a href="#modify_suggest" class="g-btn g-btn-default g-btn-sm">查看修改意见</a>
                    </div>
                </div>
            </div>

            <div class="tab-content none" tab="section" data-id="2">
                <div class="paper-txt P30 paper-section clearfix">
                    <p class="g-font-color green pull-left">
                        在学位库共找出相似内容：<span>6</span>个                    <p>
                    <div class="pull-right">
                        <a href="#modify_suggest" class="g-btn g-btn-default g-btn-sm">查看修改意见</a>                    </div>
                </div>
            </div>
            <div class="tab-content none" tab="section" data-id="3">
                <div class="paper-txt P30 paper-section clearfix">
                    <p class="g-font-color green pull-left">
                        在会议库共找出相似内容：<span>1</span>个                    <p>
                    <div class="pull-right">
                        <a href="#modify_suggest" class="g-btn g-btn-default g-btn-sm">查看修改意见</a>                    </div>
                </div>
            </div>
            <div class="tab-content none" tab="section" data-id="4">
                <div class="paper-txt P30 paper-section clearfix">
                    <p class="g-font-color green pull-left">
                        在图书库共找出相似内容：<span>3</span>个                    <p>
                    <div class="pull-right">
                        <a href="#modify_suggest" class="g-btn g-btn-default g-btn-sm">查看修改意见</a>                    </div>
                </div>
            </div>
            <div class="tab-content none" tab="section" data-id="5">
                <div class="paper-txt P30 paper-section clearfix">
                    <p class="g-font-color green pull-left">
                        在互联网库中没有找到与此句话相似的内容                    <p>
                    <div class="pull-right">
                                            </div>
                </div>
            </div>
            <!-- 自建库 -->
            <div class="tab-content none" tab="section" data-id="6">
                <div class="paper-txt P30 paper-section clearfix">
                    <p class="g-font-color green pull-left">
                        在自建库中没有找到与此句话相似的内容                    <p>
                    <div class="pull-right">
                                            </div>
                </div>
            </div>
                        <div class="tab-content" tab="section" data-id="all">
                <div class="paper-txt P30 paper-section clearfix">
                    <p class="g-font-color green pull-left">
                        在本地库和互联网库共找出相似内容：<span>16</span>个
                    <p>
                    <div class="pull-right">
                        <a href="#modify_suggest" class="g-btn g-btn-default g-btn-sm">查看修改意见</a>

                    </div>
                </div>
            </div>
            <div class="tab-content none" tab="section" data-id="local">
                <div class="paper-txt P30 paper-section clearfix">
                    <p class="g-font-color green pull-left">
                        在本地库共找出相似内容：<span>16</span>个                    <p>
                    <div class="pull-right">
                        <a href="#modify_suggest" class="g-btn g-btn-default g-btn-sm">查看修改意见</a>
                    </div>
                </div>
            </div>
        </div>



                <div class="tab-content" tab="section" data-id="学术期刊">
            <div>
                <div class="g-line-row"></div>
                <div class="paper-txt P30">
                    <div class="paper-section" style="margin-bottom:0;">
                        <div class="clearfix">
                            <div class="pull-left">
                                <span class="chapter-symbol"></span>
                                <span class="chapter-num">1</span>

                            </div>
                            <div class="font-bold pull-right">
                                相似度：<span class="g-font-color orange similarNum">54%</span>
                            </div>
                        </div>
                        <div class="MT10">
                            <p class="font-bold">您的句子：</p>
                            <p class="g-font-color orange">两组<span class="g-underline-text">总</span>体的<span class="g-underline-text">中</span><span class="g-underline-text">位</span><span class="g-underline-text">无</span><span class="g-underline-text">进展</span><span class="g-underline-text">生存</span><span class="g-underline-text">期</span>及<span class="g-underline-text">总</span><span class="g-underline-text">生存</span><span class="g-underline-text">期</span><span class="g-underline-text">为</span>5.5<span class="g-underline-text">个</span><span class="g-underline-text">月</span>和12.5<span class="g-underline-text">个</span><span class="g-underline-text">月</span>。</p>

                        </div>
                        <div class="MT10">
                            <p class="font-bold">相似句子：</p>
                            <p class="g-font-color green"><span class="g-underline-text">期</span>临床研究，<span class="g-underline-text">中</span><span class="g-underline-text">位</span><span class="g-underline-text">无</span><span class="g-underline-text">进展</span><span class="g-underline-text">生存</span><span class="g-underline-text">期</span><span class="g-underline-text">为</span>7<span class="g-underline-text">个</span><span class="g-underline-text">月</span>，<span class="g-underline-text">中</span><span class="g-underline-text">位</span><span class="g-underline-text">总</span><span class="g-underline-text">生存</span><span class="g-underline-text">期</span><span class="g-underline-text">为</span>12.6<span class="g-underline-text">个</span><span class="g-underline-text">月</span>。</p>
                        </div>
                        <div class="MT10">
                            <p class="font-bold">相似原文片段：</p>
                            腹泻及蛋白尿。临床前期数据未显示厄洛替尼和Avastin二者间存在药代动力学相互作用。8例患者（20%）部分缓解，26例患者（65.0%）病情稳定，其中34例患者进入Ⅱ<span class="g-font-color green">期临床研究，中位无进展生存期为7个月，中位总生存期为12.6个月。</span>一项Ⅱ期临床试验[12]洛替尼（150mg/d），Avastin+单药化疗（多西他塞[75]                        </div>
                        <div class="MT10">
                            <p class="font-bold">来源（学术期刊）：</p>
                            <div class="local-source-detail">
                                <b>篇名：</b>《贝伐单抗治疗进展期非小细胞肺癌临床疗效及安全性观察》<br><b>作者：</b>赵晓辉<br><b>作者单位：</b>辽宁医学院附属第一医院肿瘤科,辽宁省锦州市,121001<br><b>参考文献：</b>18篇<br><b>页码：</b>P1351—P1354<br><b>分类号：</b>R246.5<br><b>机标分类号：</b>R73 R97<br><b>期刊名称：</b>《中国肿瘤临床》<br><b>出版时间：</b>2011年21期<br><b>期刊级别：</b>ISTIC - PKU<br><b>ISSN：</b>1000-8179<br><b>关键词：</b>贝伐单抗 肺肿瘤 疗效 安全性<br><b>摘要：</b>贝伐单抗是重组人源化血管内皮生长因子(vascular endothelial growth factor,VEGF)的IgG1型单克隆抗体,能与所有VEGF异构体结合,从而阻断VEGF与VEGFR结合,以抑制VEGF活性,是一种抑制血管生成的靶向治疗药物,联合化疗用于非鳞型非小细胞肺癌的一线治疗,可以延长无进展生存期及总生存期,提高有效率;2006年10月美国FDA推荐贝伐单抗联合紫杉醇/卡铂化疗方案用于非鳞型非小细胞肺癌的一线治疗.贝伐单抗治疗的安全性受到广泛关注,最常见的不良反应包括高血压、蛋白尿、血管栓塞、出血等,相关不良反应不容忽视,但高血压、蛋白尿、血管栓塞等可以通过对症处理得到控制,且与常规化疗药物不良反应不相互重叠,与化疗药物联合应用安全性较高,多数患者耐受性良好.本文就贝伐单抗治疗进展期非小细胞肺癌临床疗效及安全性进行综述.
                            </div>
                        </div>
                    </div>
                </div>

            </div>

        </div>
                    <div class="tab-content" tab="section" data-id="学位论文">
            <div>
                <div class="g-line-row"></div>
                <div class="paper-txt P30">
                    <div class="paper-section" style="margin-bottom:0;">
                        <div class="clearfix">
                            <div class="pull-left">
                                <span class="chapter-symbol"></span>
                                <span class="chapter-num">2</span>

                            </div>
                            <div class="font-bold pull-right">
                                相似度：<span class="g-font-color orange similarNum">51%</span>
                            </div>
                        </div>
                        <div class="MT10">
                            <p class="font-bold">您的句子：</p>
                            <p class="g-font-color orange">两组<span class="g-underline-text">总</span>体的<span class="g-underline-text">中</span><span class="g-underline-text">位</span><span class="g-underline-text">无</span><span class="g-underline-text">进展</span><span class="g-underline-text">生存</span><span class="g-underline-text">期</span>及<span class="g-underline-text">总</span><span class="g-underline-text">生存</span><span class="g-underline-text">期</span><span class="g-underline-text">为</span>5.5<span class="g-underline-text">个</span><span class="g-underline-text">月</span><span class="g-underline-text">和</span>12.5<span class="g-underline-text">个</span><span class="g-underline-text">月</span>。</p>

                        </div>
                        <div class="MT10">
                            <p class="font-bold">相似句子：</p>
                            <p class="g-font-color green">31%：<span class="g-underline-text">中</span><span class="g-underline-text">位</span><span class="g-underline-text">无</span><span class="g-underline-text">进展</span><span class="g-underline-text">生存</span><span class="g-underline-text">期</span><span class="g-underline-text">和</span><span class="g-underline-text">中</span><span class="g-underline-text">位</span><span class="g-underline-text">总</span><span class="g-underline-text">生存</span><span class="g-underline-text">期</span>分别<span class="g-underline-text">为</span>18<span class="g-underline-text">月</span><span class="g-underline-text">和</span>38<span class="g-underline-text">个</span><span class="g-underline-text">月</span>【2引。</p>
                        </div>
                        <div class="MT10">
                            <p class="font-bold">相似原文片段：</p>
                            残瘤病灶超过1cm的病人随机分入TP或过去的一个标准方案CD(Cycliphosphamide+Cisplatin)组。在216名病灶可测量的病人中，TP和CD有效率分别为73%和60%，CR为51%和<span class="g-font-color green">31%：中位无进展生存期和中位总生存期分别为18月和38个月【2引。</span>OVolO临床实验收集680例IIb～Ⅳ期达到或未达到理想的肿瘤细胞减灭术的患者，TP总有效率                        </div>
                        <div class="MT10">
                            <p class="font-bold">来源（学位论文）：</p>
                            <div class="local-source-detail">
                                <b>篇名：</b>《紫杉烷与铂类联合化疗（TP）治疗卵巢上皮性癌的临床疗效观察》<br><b>作者：</b>周俊霞<br><b>分类号：</b>R730.53<br><b>学科专业：</b>肿瘤学<br><b>授予学位：</b>硕士<br><b>导师姓名：</b>刘开江<br><b>学位授予单位：</b>新疆医科大学<br><b>学位年度：</b>2008<br><b>关键词：</b>卵巢上皮性癌 紫杉烷 顺铂 联合化疗 临床疗效
                            </div>
                        </div>
                    </div>
                </div>

            </div>

        </div>
                    <div class="tab-content" tab="section" data-id="书籍数据">
            <div>
                <div class="g-line-row"></div>
                <div class="paper-txt P30">
                    <div class="paper-section" style="margin-bottom:0;">
                        <div class="clearfix">
                            <div class="pull-left">
                                <span class="chapter-symbol"></span>
                                <span class="chapter-num">3</span>

                            </div>
                            <div class="font-bold pull-right">
                                相似度：<span class="g-font-color orange similarNum">49%</span>
                            </div>
                        </div>
                        <div class="MT10">
                            <p class="font-bold">您的句子：</p>
                            <p class="g-font-color orange">两组总体的<span class="g-underline-text">中</span><span class="g-underline-text">位</span><span class="g-underline-text">无</span><span class="g-underline-text">进展</span><span class="g-underline-text">生存</span><span class="g-underline-text">期</span>及总<span class="g-underline-text">生存</span><span class="g-underline-text">期</span><span class="g-underline-text">为</span>5.5<span class="g-underline-text">个</span><span class="g-underline-text">月</span><span class="g-underline-text">和</span>12.5<span class="g-underline-text">个</span><span class="g-underline-text">月</span>。</p>

                        </div>
                        <div class="MT10">
                            <p class="font-bold">相似句子：</p>
                            <p class="g-font-color green">8．2<span class="g-underline-text">个</span><span class="g-underline-text">月</span>，<span class="g-underline-text">中</span><span class="g-underline-text">位</span><span class="g-underline-text">无</span><span class="g-underline-text">进展</span><span class="g-underline-text">生存</span><span class="g-underline-text">期</span>分别<span class="g-underline-text">为</span>5．1<span class="g-underline-text">个</span><span class="g-underline-text">月</span><span class="g-underline-text">和</span>4．4<span class="g-underline-text">个</span><span class="g-underline-text">月</span>，均</p>
                        </div>
                        <div class="MT10">
                            <p class="font-bold">相似原文片段：</p>
                            总生存率提高（危险度0．90）（P 0．001），GEM/铂类组与其他化疗组的1年生存率分别为38．9%和35%，中位生存期分别为9个月和<span class="g-font-color green">8．2个月，中位无进展生存期分别为5．1个月和4．4个月，均</span>有显著性统计学意义。与其他含铂类化疗方案相比，应用GEM/铂类化疗方案治疗非小细胞                        </div>
                        <div class="MT10">
                            <p class="font-bold">来源（书籍数据）：</p>
                            <div class="local-source-detail">
                                <br><b>书名：</b>《肿瘤内科疾病临床治疗与合理用药》<br><b>作者：</b>潘宏铭, 徐农<br><b>出版社：</b>科学技术文献出版社<br><b>出版时间：</b>2007-1-1<br><b>ISBN：</b>978-7-5023-5463-3
                            </div>
                        </div>
                    </div>
                </div>

            </div>

        </div>
                    <div class="tab-content" tab="section" data-id="学位论文">
            <div>
                <div class="g-line-row"></div>
                <div class="paper-txt P30">
                    <div class="paper-section" style="margin-bottom:0;">
                        <div class="clearfix">
                            <div class="pull-left">
                                <span class="chapter-symbol"></span>
                                <span class="chapter-num">4</span>

                            </div>
                            <div class="font-bold pull-right">
                                相似度：<span class="g-font-color orange similarNum">48%</span>
                            </div>
                        </div>
                        <div class="MT10">
                            <p class="font-bold">您的句子：</p>
                            <p class="g-font-color orange">两组<span class="g-underline-text">总</span>体的中位无进展<span class="g-underline-text">生存</span><span class="g-underline-text">期</span>及<span class="g-underline-text">总</span><span class="g-underline-text">生存</span><span class="g-underline-text">期</span>为5.5<span class="g-underline-text">个</span><span class="g-underline-text">月</span><span class="g-underline-text">和</span>12.5<span class="g-underline-text">个</span><span class="g-underline-text">月</span>。</p>

                        </div>
                        <div class="MT10">
                            <p class="font-bold">相似句子：</p>
                            <p class="g-font-color green"><span class="g-underline-text">月</span><span class="g-underline-text">和</span>5.6<span class="g-underline-text">个</span><span class="g-underline-text">月</span>。<span class="g-underline-text">总</span><span class="g-underline-text">生存</span><span class="g-underline-text">期</span>(OS)是9.3<span class="g-underline-text">个</span><span class="g-underline-text">月</span><span class="g-underline-text">和</span>10.5<span class="g-underline-text">个</span><span class="g-underline-text">月</span>，</p>
                        </div>
                        <div class="MT10">
                            <p class="font-bold">相似原文片段：</p>
                            ，但前者安全性更优。另一组对照试验，FP（5-FU+顺铂）方案和XP（卡培他滨+顺铂）方案相比较[42]。无进展生存(PFS)分别为5.0个<span class="g-font-color green">月和5.6个月。总生存期(OS)是9.3个月和10.5个月，</span>无显著差异。在欧洲，一项大型对照试验[43]采用对比标准疗法：表柔比星+顺铂+                        </div>
                        <div class="MT10">
                            <p class="font-bold">来源（学位论文）：</p>
                            <div class="local-source-detail">
                                <b>篇名：</b>《进展期胃癌的治疗进展》<br><b>作者：</b>刘培林<br><b>学科专业：</b>临床医学(放射医学)<br><b>授予学位：</b>硕士<br><b>导师姓名：</b>田野<br><b>学位授予单位：</b>苏州大学<br><b>学位年度：</b>2014<br><b>关键词：</b>晚期胃癌 化疗 靶向治疗 放疗 腹腔灌注化疗 最佳支持治疗
                            </div>
                        </div>
                    </div>
                </div>

            </div>

        </div>
                    <div class="tab-content" tab="section" data-id="学术会议">
            <div>
                <div class="g-line-row"></div>
                <div class="paper-txt P30">
                    <div class="paper-section" style="margin-bottom:0;">
                        <div class="clearfix">
                            <div class="pull-left">
                                <span class="chapter-symbol"></span>
                                <span class="chapter-num">5</span>

                            </div>
                            <div class="font-bold pull-right">
                                相似度：<span class="g-font-color orange similarNum">48%</span>
                            </div>
                        </div>
                        <div class="MT10">
                            <p class="font-bold">您的句子：</p>
                            <p class="g-font-color orange">两组<span class="g-underline-text">总</span>体的<span class="g-underline-text">中</span><span class="g-underline-text">位</span><span class="g-underline-text">无</span><span class="g-underline-text">进展</span><span class="g-underline-text">生存</span><span class="g-underline-text">期</span>及<span class="g-underline-text">总</span><span class="g-underline-text">生存</span><span class="g-underline-text">期</span><span class="g-underline-text">为</span>5.5<span class="g-underline-text">个</span><span class="g-underline-text">月</span><span class="g-underline-text">和</span>12.5<span class="g-underline-text">个</span><span class="g-underline-text">月</span>。</p>

                        </div>
                        <div class="MT10">
                            <p class="font-bold">相似句子：</p>
                            <p class="g-font-color green">有效率<span class="g-underline-text">为</span>27%，<span class="g-underline-text">中</span><span class="g-underline-text">位</span><span class="g-underline-text">无</span><span class="g-underline-text">进展</span><span class="g-underline-text">期</span><span class="g-underline-text">和</span><span class="g-underline-text">总</span><span class="g-underline-text">生存</span><span class="g-underline-text">期</span>分别<span class="g-underline-text">为</span>4<span class="g-underline-text">个</span><span class="g-underline-text">月</span><span class="g-underline-text">和</span>7．5<span class="g-underline-text">个</span><span class="g-underline-text">月</span>，</p>
                        </div>
                        <div class="MT10">
                            <p class="font-bold">相似原文片段：</p>
                            中位生存期在3"-"6mo(有些可达lOmo)，约6%～10%病人生存时间 1年。Ghosn等报道30例晚期PC患者接受5-Fu/亚叶酸/奥沙利铂治疗，客观<span class="g-font-color green">有效率为27%，中位无进展期和总生存期分别为4个月和7．5个月，</span>药物不良反应分别为包括27%的白细胞降低，10%血小板减少，和10%贫血。作为治疗PC的                        </div>
                        <div class="MT10">
                            <p class="font-bold">来源（学术会议）：</p>
                            <div class="local-source-detail">
                                <b>篇名：</b>《胰腺癌的化学药物治疗》<br><b>作者：</b>郭晓钟 穆振斌<br><b>作者单位：</b>沈阳军区总医院消化内科<br><b>会议名称：</b>中华医学会第八次全国消化疾病学术会议<br><b>主办单位：</b>中华医学会消化病学分会<br><b>会议时间：</b>2008-10-10<br><b>会议地点：</b>西安<br><b>关键词：</b>胰腺肿瘤 癌症治疗 药物化疗 化疗策略
                            </div>
                        </div>
                    </div>
                </div>

            </div>

        </div>
                    <div class="tab-content" tab="section" data-id="学术期刊">
            <div>
                <div class="g-line-row"></div>
                <div class="paper-txt P30">
                    <div class="paper-section" style="margin-bottom:0;">
                        <div class="clearfix">
                            <div class="pull-left">
                                <span class="chapter-symbol"></span>
                                <span class="chapter-num">6</span>

                            </div>
                            <div class="font-bold pull-right">
                                相似度：<span class="g-font-color orange similarNum">47%</span>
                            </div>
                        </div>
                        <div class="MT10">
                            <p class="font-bold">您的句子：</p>
                            <p class="g-font-color orange">两组总体的<span class="g-underline-text">中</span><span class="g-underline-text">位</span><span class="g-underline-text">无</span><span class="g-underline-text">进展</span><span class="g-underline-text">生存</span><span class="g-underline-text">期</span>及总<span class="g-underline-text">生存</span><span class="g-underline-text">期</span><span class="g-underline-text">为</span>5.5<span class="g-underline-text">个</span><span class="g-underline-text">月</span><span class="g-underline-text">和</span>12.5<span class="g-underline-text">个</span><span class="g-underline-text">月</span>。</p>

                        </div>
                        <div class="MT10">
                            <p class="font-bold">相似句子：</p>
                            <p class="g-font-color green"><span class="g-underline-text">位</span><span class="g-underline-text">生存</span><span class="g-underline-text">期</span><span class="g-underline-text">和</span><span class="g-underline-text">中</span><span class="g-underline-text">位</span><span class="g-underline-text">无</span><span class="g-underline-text">进展</span><span class="g-underline-text">生存</span><span class="g-underline-text">期</span>分别<span class="g-underline-text">为</span>23<span class="g-underline-text">个</span><span class="g-underline-text">月</span><span class="g-underline-text">和</span>19<span class="g-underline-text">个</span><span class="g-underline-text">月</span>。1年、2年<span class="g-underline-text">生存</span>率</p>
                        </div>
                        <div class="MT10">
                            <p class="font-bold">相似原文片段：</p>
                            时间为33．7个月，2年生存率为54%。Balandraud等12l治疗38例患者，用5．Fu加顺铂联合45Gy总剂量放疗，然后进行手术，凡切除率为89%。获得的中<span class="g-font-color green">位生存期和中位无进展生存期分别为23个月和19个月。1年、2年生存率</span>达到70．7%和45．6%。表明传统的5一Fu加顺铂方案不仅提高了手术切除率，                        </div>
                        <div class="MT10">
                            <p class="font-bold">来源（学术期刊）：</p>
                            <div class="local-source-detail">
                                <b>篇名：</b>《胃癌同期化放疗临床研究进展》<br><b>作者：</b>谈华阳 李苏宜<br><b>作者单位：</b>东南大学附属中大医院临床肿瘤中心,江苏,南京,210009<br><b>参考文献：</b>20篇<br><b>被引次数：</b>1次（统计时间：2015年8月）<br><b>页码：</b>P593—P595<br><b>页数：</b>3页<br><b>分类号：</b>R735.2<br><b>机标分类号：</b>R73 R<br><b>期刊名称：</b>《中国肿瘤》<br><b>出版时间：</b>2008年7期<br><b>期刊级别：</b>ISTIC<br><b>ISSN：</b>1004-0242<br><b>关键词：</b>胃肿瘤 新辅助同期化放疗 辅助同期化放疗<br><b>摘要：</b>全文综述胃癌新辅助和辅助同期化放疗的临床疗效.新辅助同期化放疗巾紫杉类药物被广泛看好;辅助同期化放疗较早用于临床,通常是5-Fu加 LV(四氢叶酸钙)联合放疗,同时其它化疗药物的使用也在探索之中.
                            </div>
                        </div>
                    </div>
                </div>

            </div>

        </div>
                    <div class="tab-content" tab="section" data-id="学术期刊">
            <div>
                <div class="g-line-row"></div>
                <div class="paper-txt P30">
                    <div class="paper-section" style="margin-bottom:0;">
                        <div class="clearfix">
                            <div class="pull-left">
                                <span class="chapter-symbol"></span>
                                <span class="chapter-num">7</span>

                            </div>
                            <div class="font-bold pull-right">
                                相似度：<span class="g-font-color orange similarNum">47%</span>
                            </div>
                        </div>
                        <div class="MT10">
                            <p class="font-bold">您的句子：</p>
                            <p class="g-font-color orange">两组总体的<span class="g-underline-text">中</span><span class="g-underline-text">位</span>无进展<span class="g-underline-text">生存</span><span class="g-underline-text">期</span>及总<span class="g-underline-text">生存</span><span class="g-underline-text">期</span>为5.5<span class="g-underline-text">个</span><span class="g-underline-text">月</span>和12.5<span class="g-underline-text">个</span><span class="g-underline-text">月</span>。</p>

                        </div>
                        <div class="MT10">
                            <p class="font-bold">相似句子：</p>
                            <p class="g-font-color green">吸烟者安慰剂(n=42)<span class="g-underline-text">中</span><span class="g-underline-text">位</span><span class="g-underline-text">生存</span><span class="g-underline-text">期</span>5.6<span class="g-underline-text">个</span><span class="g-underline-text">月</span><span class="g-underline-text">中</span><span class="g-underline-text">位</span><span class="g-underline-text">生存</span><span class="g-underline-text">期</span>12.3<span class="g-underline-text">个</span><span class="g-underline-text">月</span></p>
                        </div>
                        <div class="MT10">
                            <p class="font-bold">相似原文片段：</p>
                            有相关性，但与生存期则不相关。因此，目前在临床应用药物之前不必进行EGFR基因突变情况的筛查试验。参考文献图5目前/既往吸烟者能从特罗凯治疗中获益目前/既往吸烟者†不<span class="g-font-color green">吸烟者安慰剂(n=42)中位生存期5.6个月中位生存期12.3个月</span>时间(月)生存中位生存期4.6个月中位生存期5.5个月生存率时间(月                        </div>
                        <div class="MT10">
                            <p class="font-bold">来源（学术期刊）：</p>
                            <div class="local-source-detail">
                                <b>篇名：</b>《BR.21研究解读》<br><b>作者：</b>周彩存<br><b>参考文献：</b>6篇<br><b>页码：</b>P626—P628<br><b>页数：</b>3页<br><b>分类号：</b>R73<br><b>机标分类号：</b>R73 R81<br><b>期刊名称：</b>《中国肺癌杂志》<br><b>出版时间：</b>2009年6期<br><b>期刊级别：</b>ISTIC<br><b>ISSN：</b>1009-3419
                            </div>
                        </div>
                    </div>
                </div>

            </div>

        </div>
                    <div class="tab-content" tab="section" data-id="学位论文">
            <div>
                <div class="g-line-row"></div>
                <div class="paper-txt P30">
                    <div class="paper-section" style="margin-bottom:0;">
                        <div class="clearfix">
                            <div class="pull-left">
                                <span class="chapter-symbol"></span>
                                <span class="chapter-num">8</span>

                            </div>
                            <div class="font-bold pull-right">
                                相似度：<span class="g-font-color orange similarNum">47%</span>
                            </div>
                        </div>
                        <div class="MT10">
                            <p class="font-bold">您的句子：</p>
                            <p class="g-font-color orange">两组总体的<span class="g-underline-text">中</span><span class="g-underline-text">位</span>无进展<span class="g-underline-text">生存</span><span class="g-underline-text">期</span>及总<span class="g-underline-text">生存</span><span class="g-underline-text">期</span><span class="g-underline-text">为</span>5.5<span class="g-underline-text">个</span><span class="g-underline-text">月</span><span class="g-underline-text">和</span>12.5<span class="g-underline-text">个</span><span class="g-underline-text">月</span>。</p>

                        </div>
                        <div class="MT10">
                            <p class="font-bold">相似句子：</p>
                            <p class="g-font-color green"><span class="g-underline-text">月</span><span class="g-underline-text">和</span>11.5<span class="g-underline-text">个</span><span class="g-underline-text">月</span>:<span class="g-underline-text">中</span><span class="g-underline-text">位</span><span class="g-underline-text">生存</span><span class="g-underline-text">期</span>分别<span class="g-underline-text">为</span>20.4<span class="g-underline-text">个</span><span class="g-underline-text">月</span><span class="g-underline-text">和</span>21.5<span class="g-underline-text">个</span><span class="g-underline-text">月</span>。该</p>
                        </div>
                        <div class="MT10">
                            <p class="font-bold">相似原文片段：</p>
                            .5个月和8.1个月:二线治疗的有效率分别为15%和4%，二线治疗疾病稳定分别为67%和9%，入组至三线治疗后中位至进展时间分别为14.4个<span class="g-font-color green">月和11.5个月:中位生存期分别为20.4个月和21.5个月。该</span>研究主要终点是至进展时间，两种用药次序在至进展时间和总的生存期方面差别无统计学意义                        </div>
                        <div class="MT10">
                            <p class="font-bold">来源（学位论文）：</p>
                            <div class="local-source-detail">
                                <b>篇名：</b>《p14ARF基因联合5FU对人结肠癌LOVO细胞作用的研究》<br><b>作者：</b>张文<br><b>分类号：</b>R730.51<br><b>学科专业：</b>肿瘤学<br><b>授予学位：</b>硕士<br><b>导师姓名：</b>许立功<br><b>学位授予单位：</b>复旦大学<br><b>学位年度：</b>2004<br><b>关键词：</b>结直肠癌 化疗 5FU p14ARF基因
                            </div>
                        </div>
                    </div>
                </div>

            </div>

        </div>
                    <div class="tab-content" tab="section" data-id="学术期刊">
            <div>
                <div class="g-line-row"></div>
                <div class="paper-txt P30">
                    <div class="paper-section" style="margin-bottom:0;">
                        <div class="clearfix">
                            <div class="pull-left">
                                <span class="chapter-symbol"></span>
                                <span class="chapter-num">9</span>

                            </div>
                            <div class="font-bold pull-right">
                                相似度：<span class="g-font-color orange similarNum">46%</span>
                            </div>
                        </div>
                        <div class="MT10">
                            <p class="font-bold">您的句子：</p>
                            <p class="g-font-color orange">两组<span class="g-underline-text">总</span>体的<span class="g-underline-text">中</span><span class="g-underline-text">位</span>无进展<span class="g-underline-text">生存</span><span class="g-underline-text">期</span>及<span class="g-underline-text">总</span><span class="g-underline-text">生存</span><span class="g-underline-text">期</span>为5.5<span class="g-underline-text">个</span><span class="g-underline-text">月</span>和12.5<span class="g-underline-text">个</span><span class="g-underline-text">月</span>。</p>

                        </div>
                        <div class="MT10">
                            <p class="font-bold">相似句子：</p>
                            <p class="g-font-color green">0<span class="g-underline-text">个</span><span class="g-underline-text">月</span>vs4.9<span class="g-underline-text">个</span><span class="g-underline-text">月</span>；<span class="g-underline-text">中</span><span class="g-underline-text">位</span><span class="g-underline-text">总</span><span class="g-underline-text">生存</span><span class="g-underline-text">期</span>13.0<span class="g-underline-text">个</span><span class="g-underline-text">月</span>vs7.9<span class="g-underline-text">个</span><span class="g-underline-text">月</span>）</p>
                        </div>
                        <div class="MT10">
                            <p class="font-bold">相似原文片段：</p>
                            的Ⅱ期临床试验结果，联合方案较单药方案在总生存期、无进展生存期及总缓解率方面显示较明显获益（总缓解率22.6%vs3.4%；中位无进展生存期8.<span class="g-font-color green">0个月vs4.9个月；中位总生存期13.0个月vs7.9个月）</span>，但联合化疗组血液学及皮疹等不良反应较。GEM联合卡培他滨方面，有3项临床研究与                        </div>
                        <div class="MT10">
                            <p class="font-bold">来源（学术期刊）：</p>
                            <div class="local-source-detail">
                                <b>篇名：</b>《晚期胰腺癌的内科治疗现状》<br><b>作者：</b>尼露排·阿布都热黑依木 张弘纲<br><b>作者单位：</b>国家癌症中心/中国医学科学院北京协和医学院肿瘤医院内科,北京,1000210<br><b>参考文献：</b>57篇<br><b>页码：</b>P371—P376<br><b>页数：</b>6页<br><b>分类号：</b>R735.9<br><b>期刊名称：</b>《癌症进展》<br><b>出版时间：</b>2017年4期<br><b>期刊级别：</b>ISTIC<br><b>ISSN：</b>1672-1535<br><b>关键词：</b>晚期胰腺癌 化疗 靶向治疗 免疫治疗<br><b>摘要：</b>近年来胰腺癌发病率越来越高,且预后较差,治疗颇为棘手.多数晚期胰腺癌患者的治疗以内科化疗为主,同时根据病情予放射治疗、同步放化疗、靶向治疗、免疫治疗及介入治疗等.传统化疗以吉西他滨、氟尿嘧啶、铂类为主,但疗效欠佳,纳米微粒型白蛋白结合型紫杉醇、激酶抑制剂(如厄洛替尼)、单克隆抗体(如尼妥珠单抗)等药物目前无显著阳性结果,免疫治疗方面相关临床研究结果不足,故寻求有效安全的内科治疗是目前晚期胰腺癌研究的主要攻点.本文就晚期胰腺癌的内科治疗现状作一综述.
                            </div>
                        </div>
                    </div>
                </div>

            </div>

        </div>
                    <div class="tab-content" tab="section" data-id="学术期刊">
            <div>
                <div class="g-line-row"></div>
                <div class="paper-txt P30">
                    <div class="paper-section" style="margin-bottom:0;">
                        <div class="clearfix">
                            <div class="pull-left">
                                <span class="chapter-symbol"></span>
                                <span class="chapter-num">10</span>

                            </div>
                            <div class="font-bold pull-right">
                                相似度：<span class="g-font-color orange similarNum">46%</span>
                            </div>
                        </div>
                        <div class="MT10">
                            <p class="font-bold">您的句子：</p>
                            <p class="g-font-color orange">两<span class="g-underline-text">组</span>总体<span class="g-underline-text">的</span><span class="g-underline-text">中</span><span class="g-underline-text">位</span>无进展<span class="g-underline-text">生存</span><span class="g-underline-text">期</span><span class="g-underline-text">及</span>总<span class="g-underline-text">生存</span><span class="g-underline-text">期</span>为5.5<span class="g-underline-text">个</span><span class="g-underline-text">月</span>和12.5<span class="g-underline-text">个</span><span class="g-underline-text">月</span>。</p>

                        </div>
                        <div class="MT10">
                            <p class="font-bold">相似句子：</p>
                            <p class="g-font-color green">照<span class="g-underline-text">组</span>）<span class="g-underline-text">的</span><span class="g-underline-text">中</span><span class="g-underline-text">位</span><span class="g-underline-text">生存</span><span class="g-underline-text">期</span><span class="g-underline-text">及</span>无病<span class="g-underline-text">生存</span><span class="g-underline-text">期</span>可分别延长2.7<span class="g-underline-text">个</span><span class="g-underline-text">月</span>与2.3<span class="g-underline-text">个</span><span class="g-underline-text">月</span>，</p>
                        </div>
                        <div class="MT10">
                            <p class="font-bold">相似原文片段：</p>
                            性。结论：C-225联合标准剂量5-FU+铂类药物治疗转移性或复发头颈部鳞癌可显著延长患者的总生存期：接受联合药物治疗组（试验组）较仅接受单纯细胞毒药物治疗组（对<span class="g-font-color green">照组）的中位生存期及无病生存期可分别延长2.7个月与2.3个月，</span>治疗失败及患者的死亡风险则可分别减低41%与20%。点评：这项多中心Ⅲ期临床研究结果证实                        </div>
                        <div class="MT10">
                            <p class="font-bold">来源（学术期刊）：</p>
                            <div class="local-source-detail">
                                <b>篇名：</b>《铂类化疗联合西妥昔单抗治疗转移或复发性头颈部鳞癌》<br><b>作者：</b>陆嘉德 RiveraF MesiaR<br><b>被引次数：</b>1次（统计时间：2015年8月）<br><b>页数：</b>1页<br><b>分类号：</b>R9<br><b>机标分类号：</b>R73 R75<br><b>期刊名称：</b>《中国癌症杂志》<br><b>出版时间：</b>2009年2期<br><b>期刊级别：</b>ISTIC - PKU<br><b>ISSN：</b>1007-3639
                            </div>
                        </div>
                    </div>
                </div>

            </div>

        </div>
                    <div class="tab-content" tab="section" data-id="书籍数据">
            <div>
                <div class="g-line-row"></div>
                <div class="paper-txt P30">
                    <div class="paper-section" style="margin-bottom:0;">
                        <div class="clearfix">
                            <div class="pull-left">
                                <span class="chapter-symbol"></span>
                                <span class="chapter-num">11</span>

                            </div>
                            <div class="font-bold pull-right">
                                相似度：<span class="g-font-color orange similarNum">45%</span>
                            </div>
                        </div>
                        <div class="MT10">
                            <p class="font-bold">您的句子：</p>
                            <p class="g-font-color orange"><span class="g-underline-text">两</span><span class="g-underline-text">组</span>总体的<span class="g-underline-text">中</span><span class="g-underline-text">位</span>无进展<span class="g-underline-text">生存</span><span class="g-underline-text">期</span>及总<span class="g-underline-text">生存</span><span class="g-underline-text">期</span><span class="g-underline-text">为</span>5.5<span class="g-underline-text">个</span><span class="g-underline-text">月</span><span class="g-underline-text">和</span>12.5<span class="g-underline-text">个</span><span class="g-underline-text">月</span>。</p>

                        </div>
                        <div class="MT10">
                            <p class="font-bold">相似句子：</p>
                            <p class="g-font-color green">140例直接手术或放疗。<span class="g-underline-text">两</span><span class="g-underline-text">组</span><span class="g-underline-text">中</span><span class="g-underline-text">位</span><span class="g-underline-text">生存</span><span class="g-underline-text">期</span>分别<span class="g-underline-text">为</span>14.8<span class="g-underline-text">个</span><span class="g-underline-text">月</span><span class="g-underline-text">和</span>12.6<span class="g-underline-text">个</span><span class="g-underline-text">月</span>（</p>
                        </div>
                        <div class="MT10">
                            <p class="font-bold">相似原文片段：</p>
                            为新辅助化疗提高Ⅲa期NSCLC的术后长期生存率提供了证据。今年Matson等[65]报道以3个疗程的多西他赛对Ⅲ期肺癌患者进行新辅助化疗的结果，134例术前作新辅助治疗，<span class="g-font-color green">140例直接手术或放疗。两组中位生存期分别为14.8个月和12.6个月（</span>P 0.05），疾病进展中位期是9.0个月和7.6个月（P 0.                        </div>
                        <div class="MT10">
                            <p class="font-bold">来源（书籍数据）：</p>
                            <div class="local-source-detail">
                                <b>章节：</b>《第12章 肺癌的循证治疗学》<br><b>书名：</b>《呼吸系疾病循证治疗学》<br><b>作者：</b>张劲农<br><b>出版社：</b>武汉大学出版社<br><b>出版时间：</b>2007-01-01<br><b>ISBN：</b>978-7-307-05612-1<br><b>摘要：</b>本书从循证医学的角度，总结呼吸疾病的诊治进展，内容包括：肺功能检测、咳嗽的病因诊断和治疗、慢性哮喘和妊娠期哮喘的治疗、慢性阻塞性肺部疾病、社区获得性肺炎的病原流行病学和治疗、肺结核病、特发性间质性肺炎的循证治疗等。
                            </div>
                        </div>
                    </div>
                </div>

            </div>

        </div>
                    <div class="tab-content" tab="section" data-id="书籍数据">
            <div>
                <div class="g-line-row"></div>
                <div class="paper-txt P30">
                    <div class="paper-section" style="margin-bottom:0;">
                        <div class="clearfix">
                            <div class="pull-left">
                                <span class="chapter-symbol"></span>
                                <span class="chapter-num">12</span>

                            </div>
                            <div class="font-bold pull-right">
                                相似度：<span class="g-font-color orange similarNum">45%</span>
                            </div>
                        </div>
                        <div class="MT10">
                            <p class="font-bold">您的句子：</p>
                            <p class="g-font-color orange">两<span class="g-underline-text">组</span>总体<span class="g-underline-text">的</span><span class="g-underline-text">中</span><span class="g-underline-text">位</span>无进展<span class="g-underline-text">生存</span><span class="g-underline-text">期</span>及总<span class="g-underline-text">生存</span><span class="g-underline-text">期</span><span class="g-underline-text">为</span>5.5<span class="g-underline-text">个</span><span class="g-underline-text">月</span><span class="g-underline-text">和</span>12.5<span class="g-underline-text">个</span><span class="g-underline-text">月</span>。</p>

                        </div>
                        <div class="MT10">
                            <p class="font-bold">相似句子：</p>
                            <p class="g-font-color green">B<span class="g-underline-text">组</span>空白对照。结果A<span class="g-underline-text">组</span><span class="g-underline-text">和</span>B<span class="g-underline-text">组</span><span class="g-underline-text">的</span><span class="g-underline-text">中</span><span class="g-underline-text">位</span><span class="g-underline-text">生存</span><span class="g-underline-text">期</span>分别<span class="g-underline-text">为</span>102<span class="g-underline-text">个</span><span class="g-underline-text">月</span><span class="g-underline-text">和</span>125<span class="g-underline-text">个</span><span class="g-underline-text">月</span>;</p>
                        </div>
                        <div class="MT10">
                            <p class="font-bold">相似原文片段：</p>
                            初步认为3个周期化疗可能足够。7.晚期INS(工C的“维持治疗”法国学者Depierre等在2001年ASCO报告，应用MIP方案诱导成功的患者随机分成2组;A组NVB25m岁m2/w，<span class="g-font-color green">B组空白对照。结果A组和B组的中位生存期分别为102个月和125个月;</span>1年存活率分别为404%和523%，初步提示“维持治疗”未能改善存活。8.化疗的安全                        </div>
                        <div class="MT10">
                            <p class="font-bold">来源（书籍数据）：</p>
                            <div class="local-source-detail">
                                <b>章节：</b>《9非小细胞肺癌内科综合治疗新进展》<br><b>书名：</b>《中国临床肿瘤学教育专辑  2002》<br><b>作者：</b>吴一龙 ... [等]<br><b>出版社：</b>中山大学出版社<br><b>出版时间：</b>2002-06-01<br><b>ISBN：</b>7-306-01941-4
                            </div>
                        </div>
                    </div>
                </div>

            </div>

        </div>
                    <div class="tab-content" tab="section" data-id="学术期刊">
            <div>
                <div class="g-line-row"></div>
                <div class="paper-txt P30">
                    <div class="paper-section" style="margin-bottom:0;">
                        <div class="clearfix">
                            <div class="pull-left">
                                <span class="chapter-symbol"></span>
                                <span class="chapter-num">13</span>

                            </div>
                            <div class="font-bold pull-right">
                                相似度：<span class="g-font-color orange similarNum">44%</span>
                            </div>
                        </div>
                        <div class="MT10">
                            <p class="font-bold">您的句子：</p>
                            <p class="g-font-color orange">两<span class="g-underline-text">组</span>总体<span class="g-underline-text">的</span><span class="g-underline-text">中</span><span class="g-underline-text">位</span>无进展<span class="g-underline-text">生存</span><span class="g-underline-text">期</span>及总<span class="g-underline-text">生存</span><span class="g-underline-text">期</span><span class="g-underline-text">为</span>5.5<span class="g-underline-text">个</span><span class="g-underline-text">月</span><span class="g-underline-text">和</span>12.5<span class="g-underline-text">个</span><span class="g-underline-text">月</span>。</p>

                        </div>
                        <div class="MT10">
                            <p class="font-bold">相似句子：</p>
                            <p class="g-font-color green">疗<span class="g-underline-text">组</span><span class="g-underline-text">和</span>对照<span class="g-underline-text">组</span><span class="g-underline-text">的</span><span class="g-underline-text">中</span><span class="g-underline-text">位</span><span class="g-underline-text">生存</span><span class="g-underline-text">期</span>分别<span class="g-underline-text">为</span>9．5<span class="g-underline-text">个</span><span class="g-underline-text">月</span><span class="g-underline-text">和</span>5．5<span class="g-underline-text">个</span><span class="g-underline-text">月</span>(P=</p>
                        </div>
                        <div class="MT10">
                            <p class="font-bold">相似原文片段：</p>
                            与安慰剂随机双盲对照二、三线治和安慰剂的中位生存期分别为5．6个月和5．1个月(P=0．11)，两组无显著差异Ho。亚组分析显示东方人治<span class="g-font-color green">疗组和对照组的中位生存期分别为9．5个月和5．5个月(P=</span>0．01)、不吸烟者治疗组和对照组分别为8．9个月和6．1个月(                        </div>
                        <div class="MT10">
                            <p class="font-bold">来源（学术期刊）：</p>
                            <div class="local-source-detail">
                                <b>篇名：</b>《非小细胞肺癌的分子靶向治疗》<br><b>作者：</b>王惠杰 石远凯<br><b>作者单位：</b>中国医学科学院,中国协和医科大学,肿瘤医院内科,北京,100021<br><b>参考文献：</b>53篇<br><b>被引次数：</b>2次（统计时间：2015年8月）<br><b>页码：</b>P94—P103<br><b>页数：</b>10页<br><b>分类号：</b>R734<br><b>机标分类号：</b>R97 R73<br><b>期刊名称：</b>《癌症进展》<br><b>出版时间：</b>2006年2期<br><b>期刊级别：</b>ISTIC<br><b>ISSN：</b>1672-1535<br><b>关键词：</b>非小细胞肺癌 靶向治疗<br><b>摘要：</b>与传统细胞毒性化疗相比,分子靶向治疗能更特异性作用于肿瘤而毒性反应较轻.新的靶向治疗药物得到发展,并相继在晚期非小细胞肺癌一线、二线治疗中进行临床试验,其中有的药物显示了较好的疗效.本文对近年来关于非小细胞肺癌靶向治疗的临床试验进行回顾.
                            </div>
                        </div>
                    </div>
                </div>

            </div>

        </div>
                    <div class="tab-content" tab="section" data-id="学位论文">
            <div>
                <div class="g-line-row"></div>
                <div class="paper-txt P30">
                    <div class="paper-section" style="margin-bottom:0;">
                        <div class="clearfix">
                            <div class="pull-left">
                                <span class="chapter-symbol"></span>
                                <span class="chapter-num">14</span>

                            </div>
                            <div class="font-bold pull-right">
                                相似度：<span class="g-font-color orange similarNum">44%</span>
                            </div>
                        </div>
                        <div class="MT10">
                            <p class="font-bold">您的句子：</p>
                            <p class="g-font-color orange">两<span class="g-underline-text">组</span>总体的<span class="g-underline-text">中</span><span class="g-underline-text">位</span><span class="g-underline-text">无</span><span class="g-underline-text">进展</span><span class="g-underline-text">生存</span><span class="g-underline-text">期</span>及总<span class="g-underline-text">生存</span><span class="g-underline-text">期</span><span class="g-underline-text">为</span>5.5<span class="g-underline-text">个</span><span class="g-underline-text">月</span>和12.5<span class="g-underline-text">个</span><span class="g-underline-text">月</span>。</p>

                        </div>
                        <div class="MT10">
                            <p class="font-bold">相似句子：</p>
                            <p class="g-font-color green">年龄 51岁<span class="g-underline-text">组</span><span class="g-underline-text">中</span><span class="g-underline-text">位</span><span class="g-underline-text">无</span><span class="g-underline-text">进展</span><span class="g-underline-text">生存</span><span class="g-underline-text">期</span><span class="g-underline-text">为</span>22．OO<span class="g-underline-text">个</span><span class="g-underline-text">月</span>，年龄 51岁<span class="g-underline-text">组</span>患者<span class="g-underline-text">中</span><span class="g-underline-text">位</span><span class="g-underline-text">无</span></p>
                        </div>
                        <div class="MT10">
                            <p class="font-bold">相似原文片段：</p>
                            胡艳【l¨等回顾性分析292例上皮性卵巢癌患者临床资料，认为年龄是患者的预后相关指标，但并非其独立预后因素。本研究中，年龄≤51岁组中位无进展生存期为21个月，<span class="g-font-color green">年龄 51岁组中位无进展生存期为22．OO个月，年龄 51岁组患者中位无</span>进展生存期稍长，但结果无统计学差异(P O．05)。说明年龄对经规范治疗后IIIc                        </div>
                        <div class="MT10">
                            <p class="font-bold">来源（学位论文）：</p>
                            <div class="local-source-detail">
                                <b>篇名：</b>《Ⅲc期上皮性卵巢癌预后危险因素与无进展生存期关系探讨》<br><b>作者：</b>邱章灿<br><b>分类号：</b>R737.31<br><b>学科专业：</b>妇科肿瘤<br><b>授予学位：</b>硕士<br><b>导师姓名：</b>莫凌昭<br><b>学位授予单位：</b>广西医科大学<br><b>学位年度：</b>2015<br><b>关键词：</b>上皮性卵巢癌 预后因素 无进展生存期 临床应用
                            </div>
                        </div>
                    </div>
                </div>

            </div>

        </div>
                    <div class="tab-content" tab="section" data-id="学位论文">
            <div>
                <div class="g-line-row"></div>
                <div class="paper-txt P30">
                    <div class="paper-section" style="margin-bottom:0;">
                        <div class="clearfix">
                            <div class="pull-left">
                                <span class="chapter-symbol"></span>
                                <span class="chapter-num">15</span>

                            </div>
                            <div class="font-bold pull-right">
                                相似度：<span class="g-font-color orange similarNum">43%</span>
                            </div>
                        </div>
                        <div class="MT10">
                            <p class="font-bold">您的句子：</p>
                            <p class="g-font-color orange">两<span class="g-underline-text">组</span>总体的中位无进展<span class="g-underline-text">生存</span><span class="g-underline-text">期</span>及总<span class="g-underline-text">生存</span><span class="g-underline-text">期</span><span class="g-underline-text">为</span>5.5<span class="g-underline-text">个</span><span class="g-underline-text">月</span>和12.5<span class="g-underline-text">个</span><span class="g-underline-text">月</span>。</p>

                        </div>
                        <div class="MT10">
                            <p class="font-bold">相似句子：</p>
                            <p class="g-font-color green">：A<span class="g-underline-text">组</span><span class="g-underline-text">为</span><span class="g-underline-text">生存</span><span class="g-underline-text">期</span>小于12<span class="g-underline-text">个</span><span class="g-underline-text">月</span>，B<span class="g-underline-text">组</span><span class="g-underline-text">为</span><span class="g-underline-text">生存</span><span class="g-underline-text">期</span>大于12<span class="g-underline-text">个</span><span class="g-underline-text">月</span>小于24<span class="g-underline-text">个</span><span class="g-underline-text">月</span>，C<span class="g-underline-text">组</span></p>
                        </div>
                        <div class="MT10">
                            <p class="font-bold">相似原文片段：</p>
                            内科治疗(化疗和靶向)的疾病进展时间(TTP)，并以患者性别、年龄、卡氏评分、病理分型作为变量，探讨各变量对晚期非小细胞肺癌的近期疗效影响；将157例患者分成3组<span class="g-font-color green">：A组为生存期小于12个月，B组为生存期大于12个月小于24个月，C组</span>为生存期大于24个月。将性别、年龄、卡氏评分【见附录3】、临床分期、病理分型                        </div>
                        <div class="MT10">
                            <p class="font-bold">来源（学位论文）：</p>
                            <div class="local-source-detail">
                                <b>篇名：</b>《影响晚期非小细胞肺癌治疗效果的临床因素分析》<br><b>作者：</b>周秀开<br><b>分类号：</b>R734.2<br><b>学科专业：</b>肿瘤学<br><b>授予学位：</b>硕士<br><b>导师姓名：</b>孙秀华<br><b>学位授予单位：</b>大连医科大学<br><b>学位年度：</b>2010<br><b>关键词：</b>晚期非小细胞肺癌 治疗效果 临床因素
                            </div>
                        </div>
                    </div>
                </div>

            </div>

        </div>
                    <div class="tab-content" tab="section" data-id="学位论文">
            <div>
                <div class="g-line-row"></div>
                <div class="paper-txt P30">
                    <div class="paper-section" style="margin-bottom:0;">
                        <div class="clearfix">
                            <div class="pull-left">
                                <span class="chapter-symbol"></span>
                                <span class="chapter-num">16</span>

                            </div>
                            <div class="font-bold pull-right">
                                相似度：<span class="g-font-color orange similarNum">42%</span>
                            </div>
                        </div>
                        <div class="MT10">
                            <p class="font-bold">您的句子：</p>
                            <p class="g-font-color orange">两组<span class="g-underline-text">总</span>体<span class="g-underline-text">的</span>中位<span class="g-underline-text">无</span><span class="g-underline-text">进展</span><span class="g-underline-text">生存</span><span class="g-underline-text">期</span><span class="g-underline-text">及</span><span class="g-underline-text">总</span><span class="g-underline-text">生存</span><span class="g-underline-text">期</span>为5.5<span class="g-underline-text">个</span><span class="g-underline-text">月</span>和12.5<span class="g-underline-text">个</span><span class="g-underline-text">月</span>。</p>

                        </div>
                        <div class="MT10">
                            <p class="font-bold">相似句子：</p>
                            <p class="g-font-color green">病例<span class="g-underline-text">总</span><span class="g-underline-text">的</span><span class="g-underline-text">生存</span>、局部控制<span class="g-underline-text">及</span><span class="g-underline-text">无</span><span class="g-underline-text">进展</span><span class="g-underline-text">生存</span>情况研究论文<span class="g-underline-text">生存</span><span class="g-underline-text">期</span>以6<span class="g-underline-text">个</span><span class="g-underline-text">月</span>、12<span class="g-underline-text">个</span><span class="g-underline-text">月</span>进行评价。</p>
                        </div>
                        <div class="MT10">
                            <p class="font-bold">相似原文片段：</p>
                            时应用“食管癌近期疗效评价标准”对所有患者进行评价，累及野组和扩大野组甲级、乙级、丙级分别为96．67%。两组无统计学差异(胗O．05)。3本研究中<span class="g-font-color green">病例总的生存、局部控制及无进展生存情况研究论文生存期以6个月、12个月进行评价。</span>6个月和12个月总生存率分别为77．67%和55．49%，中位生存期7个                        </div>
                        <div class="MT10">
                            <p class="font-bold">来源（学位论文）：</p>
                            <div class="local-source-detail">
                                <b>篇名：</b>《食管癌三维适形放射治疗临床靶体积前瞻性随机分组临床研究》<br><b>作者：</b>王薇<br><b>分类号：</b>R730.55<br><b>学科专业：</b>肿瘤学<br><b>授予学位：</b>硕士<br><b>导师姓名：</b>乔学英<br><b>学位授予单位：</b>河北医科大学<br><b>学位年度：</b>2008<br><b>关键词：</b>食管癌 放射治疗 三维适形 临床靶体积 随机分组
                            </div>
                        </div>
                    </div>
                </div>

            </div>

        </div>
            
        <!--语句修改建议-->
        <span id="modify_suggest"></span>
        <div id="advice">
            <div class="g-line-row"></div>
            <div class="paper-txt P30 PB0">
                <div class="paper-section">
                    <p class="g-font-s16 font-bold g-font-color green MB10">该句修改建议（轻度相似，请酌情修改）</p>
                    <span class="g-font-color green">两组<span class="g-font-color red">总</span>体的<span class="g-font-color red">中</span><span class="g-font-color red">位</span>无<span class="g-font-color red">进展</span><span class="g-font-color red">生存</span><span class="g-font-color red">期</span>及<span class="g-font-color red">总</span><span class="g-font-color red">生存</span><span class="g-font-color red">期</span>为5.5个<span class="g-font-color red">月</span>和12.5个<span class="g-font-color red">月</span>。</span>
                    <div class="MT10">
                        <p class="font-bold">同义词：</p>
                        <ul class="local-source-detail">
                            <li class="g-font-color green"><span class="g-font-color red">生存：</span>保存 保留  封存</li><li class="g-font-color green"><span class="g-font-color red">进展：</span>但愿 希望</li>
                        </ul>

                    </div>
                </div>
            </div>
        </div>
    </div>
    <div class="back-to-top text-center">
        <a href="#gototop" class="font-bold g-font-color green">回到顶部</a>
    </div>
    <div class="paper-footer">
        <p>检测报告由<a href="http://www.paperpass.com/" target="_black">PaperPass</a>文献相似度检测系统生成</p>
        <p>Copyright © 2007-2018 PaperPass</p>
    </div>
</div>
</body>
<script type="text/javascript" src="../js/jquery.min.js"></script>
<script type="text/javascript" src="../js/Lib.js"></script>
<script type="text/javascript">
    (function(System,$){
        var tab = System.Paper.tab();
        var $advice = null;
        function run(){
            var i = 0;
            $advice.show();
            tab.call(this,{callback:function(){
                var $num = $(this).find('.chapter-num');
                if($num.length>0){
                    i++;
                    $num.text(i);
                }
            }});
            //没有内容时同时不显示该句修改建议
            if(0 === i){$advice.hide();}
        }
        $(function(){
            $advice = $('#advice');
            $(document).on('click','[tab-a="ul"] li',function(){
                run.call(this);
            });
            $(document).on('click','[tab-b="ul"] li',function(){
                run.call(this);
            });
        });
    })(Report,jQuery);


</script>
</html>
